Search Results 421-430 of 12557 for alp

1. A Study of the Safety and Effectiveness of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unremoveable Malignant Pleural Mesothelioma - Mayo Clinic

   Aspartate aminotransferase less than or equal to 3 x ULN; Alanine aminotransferase less than or equal to 3 x ULN; Alkaline phosphatase less than or equal to 3 x ...

2. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

3. Amyotrophic lateral sclerosis (ALS) - Doctors and departments - Mayo Clinic

   Researchers at Mayo Clinic study the possible causes of ALS . This includes identifying biomarkers in blood and cerebrospinal fluid that might someday help to ...

4. A Study of Nab-Paclitaxel as Maintenance Treatment After Cisplatin-Based Chemotherapy and Surgery for Patients with High-Risk Bladder Cancer - Mayo Clinic

   Alkaline phosphatase ≤ 2.5 x upper limit of normal (ULN); Creatinine ≤ 1.5 mg/dL or creatinine clearance ≥ 40mL/mon (using Cockcroft-Gault formula) ...

5. Pazopanib Hydrochloride in Treating Patients with Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma - Mayo Clinic

   Alkaline phosphatase ≤ 2.5 x ULN; Creatinine ≤ 1.5 mg/dL (133 umol/L) or within normal institutional limits OR creatinine clearance ≥ 50 mL/min/1.73m^2 ...

6. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

   phosphatase (ALP) =< 5 x upper limit of normal (ULN) (obtained =< 28 days prior to randomization) - Total bilirubin =< 3 x ULN (obtained =< 28 days prior to ...

7. Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer - Mayo Clinic

   Alkaline phosphatase < 2.5 times ULN; Bilirubin ≤ 1.5 times ULN; No known uncontrolled coagulopathy. Renal. Creatinine clearance > 50 mL/min. Cardiovascular.

8. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

   Alkaline phosphatase ≤ 2.5 times the ULN. Have had a CT or MRI scan (chest, abdomen, pelvis and other suspected sites as applicable) to determine ...

9. Treatment of Pain Associated with Fibromyalgia - Mayo Clinic

   Abnormal liver function defined as aspartate aminotransferase (AST) > 2.0 × ULN, alanine aminotransferase (ALT) > 2.0 × ULN; alkaline phosphatase > 1.5 × ULN; ...

10. Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates - Mayo Clinic

    ... Alkaline phosphatase < 2.5 X upper limit of normal, unless bone metastasis is present in the absence of liver metastasis - Total bilirubin < 1.5 mg/dL ...